SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001563665-22-000019
Filing Date
2022-12-23
Accepted
2022-12-23 09:06:41
Documents
14
Period of Report
2022-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20221223x8k.htm   iXBRL 8-K 33934
2 EX-99 tmb-20221223xex99.htm EX-99 17539
3 GRAPHIC tmb-20221223xex99001.jpg GRAPHIC 9744
  Complete submission text file 0001563665-22-000019.txt   173172

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20221223.xsd EX-101.SCH 3031
5 EX-101.LAB tmb-20221223_lab.xml EX-101.LAB 14083
6 EX-101.PRE tmb-20221223_pre.xml EX-101.PRE 9201
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221223x8k_htm.xml XML 4267
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 221483495
SIC: 3841 Surgical & Medical Instruments & Apparatus